Platelet Function Assays for the Diagnosis of Aspirin Resistance

Aspirin, an antiplatelet drug, is commonly used at low doses for numerous indications, including prophylaxis of cardiovascular, neurovascular, and venous thromboembolic events. Due to review articles suggesting that aspirin resistance may result in poorer outcomes, interest in assessing platelet fun...

Full description

Bibliographic Details
Published in:	Platelets
Main Authors:	Nameer Van Oosterom, Michael Barras, Neil Cottrell, Robert Bird
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-04-01
Subjects:	aspirin blood platelets drug resistance platelet function tests venous thromboembolism
Online Access:	http://dx.doi.org/10.1080/09537104.2021.1942816

Similar Items

Artificial intelligence, platelets and aspirin
by: Giovanni de Gaetano
Published: (2024-03-01)

Blood platelets, prostaglandins and aspirin: a historical and personal rereading
by: Giovanni de Gaetano, et al.
Published: (2024-03-01)

The Incidence and Methods for Detecting Aspirin Resistance in Pediatric Patients
by: Poparn H, et al.
Published: (2024-11-01)

Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug
by: Annachiara Mitrugno, et al.
Published: (2018-11-01)

Platelets in preeclampsia: an observational study of indices associated with aspirin nonresponsiveness, activation and transcriptional landscape
by: Gashaw Garedew Woldeamanuel, et al.
Published: (2025-06-01)

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
by: Ilgın Koçak Göktürk, et al.
Published: (2023-03-01)

TRUE RESISTANCE AND PSEUDORESISTANCE TO ASPIRIN
by: A. I. Martynov, et al.
Published: (2015-09-01)

Sticky Platelet Syndrome in Patients with Uninduced Venous Thrombosis
by: Emre Tekgündüz, et al.
Published: (2013-03-01)

Platelet response to aspirin in UK and Irish pregnancy cohorts: a genome-wide approach
by: Fionnuala Mone, et al.
Published: (2022-08-01)

Aspirin resistance: causes, clinical significance, correction
by: G.F. Gendeleka, et al.
Published: (2022-04-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)

Comparison of nine platelet function tests used to determine responses to different aspirin dosages in people with type 2 diabetes
by: Paul Harrison, et al.
Published: (2019-05-01)

Increased Platelet Adhesiveness in Patients with Venous Thromboembolic Disease
by: Julia Martinez-Sanchez, et al.
Published: (2024-10-01)

Adjuvant therapeutic efficacy of low-dose aspirin on short-term outcomes of patients with cancer-associated venous thromboembolism
by: Wei Xiong, et al.
Published: (2025-07-01)

Aspirin is Not for Everyone: Discharge to Non-home Facilities After Total Hip and Knee Arthroplasty Increases Risk of Venous Thromboembolism
by: Michael McHugh, MD, et al.
Published: (2024-06-01)

Aspirin thromboprophylaxis in joint replacement surgery
by: Anish V. Sharda, et al.
Published: (2022-01-01)

Platelet count and risk of major bleeding in venous thromboembolism
by: Håkon S. Johnsen, et al.
Published: (2021-05-01)

Platelet inhibition by low-dose aspirin is not influenced by body mass or weight
by: Sean P. Heffron, et al.
Published: (2022-11-01)

Platelet count and clinical outcomes in hospitalized patients with COVID-19 pneumonia
by: Carmine Siniscalchi, et al.
Published: (2025-10-01)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01)

Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels
by: Öhlin Hans, et al.
Published: (2005-07-01)

Thrombopoietin and platelet aggregation in patients with stable coronary artery disease
by: Sanne Bøjet Larsen, et al.
Published: (2017-11-01)

Arachidonic acid causes lysis of blood cells and ADP-dependent platelet activation responses in platelet function tests
by: Sofia Ramström
Published: (2019-11-01)

The distinct effects of aspirin on platelet aggregation induced by infectious bacteria
by: Nadji Hannachi, et al.
Published: (2020-11-01)

Comparison of Intensity of Platelet Aggregation between Patients Receiving Low and High Aspirin Dosage in Post CABG Patients
by: Wanchai Wongkornrat, et al.
Published: (2020-04-01)

Venous Thromboembolism and Risk of Cancer in Users of Low-Dose Aspirin: A Danish Population-Based Cohort Study
by: Gencer Kurt, et al.
Published: (2022-07-01)

Blood loss after coronary artery bypass by aspirin responsiveness assessed with preoperative VerifyNow aspirin testing
by: Laura M. Willemsen, et al.
Published: (2021-12-01)

Pharmacodynamic Comparison of Two Aspirin Formulations in the Caribbean: The ARC Study
by: Naveen Seecheran, et al.
Published: (2024-07-01)

Influence of diagnosis of venous thromboembolism on immature platelets, absolute platelet count and platelet aggregation over time
by: Isabel Wustrow, et al.
Published: (2021-04-01)

Pro-apoptotic properties and mitochondrial functionality in platelet-like-particles generated from low Aspirin-incubated Meg-01 cells
by: Gala Freixer, et al.
Published: (2021-11-01)

Aspirin versus Rivaroxaban to Prevent Venous Thromboembolism after Total Knee Arthroplasty: A Double-blinded, Randomized Controlled Trial
by: Theerawit Hongnaparak, et al.
Published: (2022-11-01)

The aspirin resistance and platelets` receptors expression in chronic heart failure patients with type 2 diabetes mellitus
by: M. Yu. Kolesnyk, et al.
Published: (2014-06-01)

Aspirin for the extended prevention of venous thromboembolism: a meta-analysis and trial sequential analysis
by: Michele Carron, et al.
Published: (2025-05-01)

Decreased turnover aspirin resistance by bidaily aspirin intake and efficient cytoreduction in myeloproliferative neoplasms
by: Andréas Perrier-Cornet, et al.
Published: (2018-10-01)

Aspirin, platelet inhibition and cancer prevention
by: Paola Patrignani, et al.
Published: (2018-11-01)

Recovery of platelet reactivity following cessation of either aspirin or ticagrelor in patients treated with dual antiplatelet therapy following percutaneous coronary intervention: a GLOBAL LEADERS substudy
by: Barry W. Hennigan, et al.
Published: (2022-01-01)

Comparative Study of Ex Vivo Antiplatelet Activity of Aspirin and Cilostazol in Patients with Diabetes and High Risk of Cardiovascular Disease
by: Sangmo Hong, et al.
Published: (2022-04-01)

Inter-Relationship between Platelet-Derived Microparticles and Oxidative Stress in Patients with Venous Thromboembolism
by: Salvatore Santo Signorelli, et al.
Published: (2020-12-01)

Platelet Metabolism and Other Targeted Drugs; Potential Impact on Immunotherapy
by: Preeti Kanikarla-Marie, et al.
Published: (2018-04-01)